- •Parasitic and COVID-19 coinfection has become the focus of some studies.
- •Some have suggested that parasites may reduce the morbidity/mortality of COVID-19.
- •However, the poor design of these studies precludes us from drawing firm conclusions.
Financial support statement
Authors’ contribution and acknowledgments
Conflict of interest
- Helminths and COVID-19 Co-Infections: A Neglected Critical Challenge.ACS Pharmacol Transl Sci. 2020; 3: 1039-1041
- Prophylactic effect of cutaneous leishmaniasis against COVID-19: A case-control field assessment.Int J Infect Dis. 2021;
- The New Status of Parasitic Diseases in the COVID-19 Pandemic-Risk Factors or Protective Agents?.J Clin Med. 2021; 10
- Malaria and COVID-19: unmasking their ties.Malar J. 2020; 19: 457
- COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection.PLoS Negl Trop Dis. 2020; 14 (e0008853)
- Helminth Modulation of Lung Inflammation.Trends Parasitol. 2018; 34: 388-403
- Potential Influence of Helminth Molecules on COVID-19 Pathology.Trends Parasitol. 2021; 37: 11-14
- Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study.EClinicalMedicine. 2021; 39101054
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy